Sorrento Therapeutics

SRNE:NAS

Biotechnology

Market Cap

—

SMALL cap

Share Price ←

(—)

YTD Return ←

—

since start of 2020

P/E Ratio

—

Corporate Values

Carbon Footprint
Pollution Prevention
Water Conservation
Data & Privacy Protection
Consumer Health, Wellness & Safety
Employee Ownership, Satisfaction, Benefits & Pay
Workplace Health and Safety
Integrity of Corporate Governance
Ethical Practices
Usage of Conflict Materials
Forced Labor
Diversity of Corporate Leadership

About

Biotechnology Founded 2006

Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.

website

Headquarters

4955 Directors Place

San Diego, CA 92121

1.858.203.4100

Executives

Name	Title	Gender
George K. Ng	Chief Administrative Officer & Executive VP	Male
William S. Marth, MBA	Chairman	Male
Jerome B. Zeldis, MD, PhD	Chief Medical Officer	Male
Henry H. Ji, PhD	President, Chief Executive Officer & Director	Male
Kevin M. Herde, CPA	Chief Financial Officer & Executive Vice President	Male
Jeffrey Su, Phd	Chief Operating Officer & Executive Vice President	Male

Mindful Investing Summary

Carbon Footprint

— N/A
Pollution Prevention

— N/A
Water Conservation

— N/A
Data & Privacy Protection

— N/A
Consumer Health, Wellness & Safety

— N/A
Employee Ownership, Satisfaction, Benefits & Pay

— N/A
Workplace Health and Safety

— N/A
Integrity of Corporate Governance

— N/A
Ethical Practices

— N/A
Usage of Conflict Materials

— N/A
Forced Labor

— N/A
Diversity of Corporate Leadership

1 N/A

Sorrento Therapeutics - Competitors and Related Companies

How Sorrento Therapeutics stacks up to its peers in the Biotechnology industry or with competing business segments.